The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Martin, Christine Janet, Dr
    Technology Transfer Manager born in December 1969
    Individual (3 offsprings)
    Officer
    2020-12-18 ~ now
    OF - Director → CIF 0
  • 2
    Huntington, James, Professor
    University Professor born in December 1964
    Individual (7 offsprings)
    Officer
    2020-12-18 ~ now
    OF - Director → CIF 0
  • 3
    TCPI ASSET 1 LIMITED - 2013-04-10
    The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, England
    Active Corporate (4 parents, 32 offsprings)
    Equity (Company account)
    805,306 GBP2018-04-30
    Officer
    2020-07-05 ~ now
    OF - Secretary → CIF 0
Ceased 3
  • 1
    De Rubertis, Francesco
    Venture Capitalist born in January 1970
    Individual (19 offsprings)
    Officer
    2020-12-18 ~ 2024-01-17
    OF - Director → CIF 0
  • 2
    Grainger, David John, Dr
    Scientist born in October 1966
    Individual (35 offsprings)
    Officer
    2020-07-05 ~ 2024-01-17
    OF - Director → CIF 0
    Dr David John Grainger
    Born in October 1966
    Individual (35 offsprings)
    Person with significant control
    2020-07-05 ~ 2020-12-18
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
  • 3
    44, The Esplanade, Jersey, Jersey
    Corporate
    Person with significant control
    2020-12-18 ~ 2020-12-18
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
parent relation
Company in focus

SDS THERAPEUTICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Debtors
150,578 GBP2021-07-31
Cash at bank and in hand
2,773,300 GBP2021-07-31
Current Assets
2,923,878 GBP2021-07-31
Creditors
Current
158,247 GBP2021-07-31
Net Current Assets/Liabilities
2,765,631 GBP2021-07-31
Total Assets Less Current Liabilities
2,765,631 GBP2021-07-31
Equity
Called up share capital
574 GBP2021-07-31
Share premium
3,309,595 GBP2021-07-31
Retained earnings (accumulated losses)
-544,538 GBP2021-07-31
Equity
2,765,631 GBP2021-07-31
Average Number of Employees
12020-07-05 ~ 2021-07-31
Other Debtors
Current, Amounts falling due within one year
150,578 GBP2021-07-31
Trade Creditors/Trade Payables
Current
38,082 GBP2021-07-31
Other Creditors
Current
120,165 GBP2021-07-31

  • SDS THERAPEUTICS LIMITED
    Info
    Registered number 12719780
    C/o The Cambridge Partnership Limited The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge CB22 3FH
    Private Limited Company incorporated on 2020-07-05 (5 years). The company status is Active.
    The last date of confirmation statement was made at 2024-07-04
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.